Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Seven researchers to receive grants from ASTRO to advance radiation oncology research

The American Society for Radiation Oncology (ASTRO) has selected seven (7) leading researchers who will receive a total of $675,000 in awards and grants to advance radiation oncology research.

23 Aug 2013

Radiation Oncologist receives Young Investigator Award from PCF

Jefferson Radiation Oncologist, Nicole Simone, M.D., was recently awarded one of 21 Young Investigator Awards from the Prostate Cancer Foundation (PCF).

21 Aug 2013

Researchers identify key transcription factor linked with treatment-resistant prostate cancer

Prostate cancer is one of the most common forms of cancer in men and the leading cause of cancer deaths in white, African-American and Hispanic men, according to the Centers for Disease Control. Current treatment of prostate cancer targets androgens, hormones which promote the growth and spread of cancer cells.

20 Aug 2013

Docs prescribe more radiation if they have financial interest in it; Medicare's new e-prescribing ayment spurs use

Doctors who have a financial interest in prescribing radiation treatment do it more, a congressional study says. In the meantime, new Medicare payment incentives drive a rise in e-prescribing.

20 Aug 2013

NCI-PCPT explores survival of men on finasteride drug

In the NCI-sponsored Prostate Cancer Prevention Trial (PCPT), initial findings from a decade ago showed that the drug finasteride significantly reduced the risk of prostate cancer, but among those who did develop prostate cancer, paradoxically, the drug was associated with an increased risk of high-grade disease.

20 Aug 2013

Advance team of molecules produced by primary tumor is responsible for lung cancer metastasis

Cancer metastasis requires tumor cells to acquire properties that allow them to escape from the primary tumor site, travel to a distant place in the body, and form secondary tumors. But first, an advance team of molecules produced by the primary tumor sets off a series of events that create a network of nurturing blood vessels for arriving primary tumor cells to set up shop.

20 Aug 2013

First Edition: August 19, 2013

Today's headlines include reports about how public perceptions and political opposition continue to swirl around the health law's implementation.

19 Aug 2013

Basic cancer research at Creighton yields promising results for diagnosing, treating asthma

What started as basic cancer research at Creighton University has yielded promising results for diagnosing and treating asthma - and the National Institutes of Health (NIH) agrees, investing nearly $1.5 million in Creighton to find out more.

17 Aug 2013

Sugar offers noninvasive way to precisely image tumors through new imaging technology

A natural form of sugar could offer a new, noninvasive way to precisely image tumors and potentially see whether cancer medication is effective, by means of a new imaging technology developed at UC San Francisco in collaboration with GE Healthcare.

16 Aug 2013

Researchers identify key mechanism behind aggressive prostate cancer

A team of researchers from UC Davis, UC San Diego and other institutions has identified a key mechanism behind aggressive prostate cancer. Published on August 14 in Nature, the study shows that two long non-coding RNAs (PRNCR1 and PCGEM1) activate androgen receptors, circumventing androgen-deprivation therapy.

16 Aug 2013

PSA screening shows low-grade prostate cancers do not progress to higher grade over time

Prostate cancer aggressiveness may be established when the tumor is formed and not alter with time, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

14 Aug 2013

RaySearch Laboratories announces first patient treated with RayStation

RaySearch Laboratories AB announces that the first patient in Australasia has been treated with a treatment plan created with RaySearch's treatment planning system RayStation®. The treatment was carried out at Auckland Radiation Oncology in Auckland, New Zealand.

From Elekta 13 Aug 2013

NW Bio receives decision to continue Phase III clinical trial on brain cancer in Germany

Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.

12 Aug 2013

Study: Immune-regulating molecules can trigger lymphomas

A small group of immune-regulating molecules, when overproduced even moderately, can trigger the blood cancers known as lymphomas, according to a new study led by scientists from The Scripps Research Institute (TSRI).

9 Aug 2013

NCI renews UCLA prostate SPORE grant

UCLA's Jonsson Comprehensive Cancer Center and the department of urology at the David Geffen School of Medicine at UCLA have been notified that their standing as a National Cancer Institute Specialized Program of Research Excellence site in prostate cancer has been renewed for another five years.

8 Aug 2013

Study reveals nearly 40% of tumors are caused by viruses

The results of a large-scale analysis of the association between DNA viruses and human malignancies suggest that many of the most common cancers are not associated with DNA viruses.

6 Aug 2013

Viewpoints: Health law rollout needs a better salesman; the overhaul is shifting the economy to part-timers

We need a serious and sustained presidential conversation with the country about the new health care reform laws - or progressives risk losing ownership of this once-in-generation liberal reform. If you listen to people in focus group discussions right now, they are clueless about the most basic policies in the reforms, even though parts of the law are already in place, the exchanges are to be launched in October, and the law's requirements and benefits will become fully operative in January. ... And in the most recent national surveys, more people think their health insurance situation will be made worse by the impending changes (Stanley B. Greenberg, 7/30).

2 Aug 2013

Research opens potential new avenue for cancer treatment

Scientists at The University of Texas MD Anderson who identified a protein's dual role in cancer promotion have discovered a way to shut it down, opening a potential new avenue for cancer treatment.

2 Aug 2013

Study: New therapeutic approach to treat prostate cancer

A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer. Conducted at Cincinnati Children's Hospital Medical Center, the research shows that expression of the FoxM1 protein is essential for prostate cancer to develop in mouse models. The study appears in the journal's Aug. 2 edition.

2 Aug 2013

Researchers reveal how SMIP004 anticancer compound targets prostate cancer cells

One major hallmark of cancer cells is their ability to survive under stressful conditions. A new study spearheaded by researchers at Sanford-Burnham Medical Research Institute reveals how a promising anticancer compound called SMIP004 specifically kills prostate cancer cells by compromising their ability to withstand environmental stress.

31 Jul 2013

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Seven researchers to receive grants from ASTRO to advance radiation oncology research

Radiation Oncologist receives Young Investigator Award from PCF

Researchers identify key transcription factor linked with treatment-resistant prostate cancer

Docs prescribe more radiation if they have financial interest in it; Medicare's new e-prescribing ayment spurs use

NCI-PCPT explores survival of men on finasteride drug

Advance team of molecules produced by primary tumor is responsible for lung cancer metastasis

First Edition: August 19, 2013

Basic cancer research at Creighton yields promising results for diagnosing, treating asthma

Sugar offers noninvasive way to precisely image tumors through new imaging technology

Researchers identify key mechanism behind aggressive prostate cancer

PSA screening shows low-grade prostate cancers do not progress to higher grade over time

RaySearch Laboratories announces first patient treated with RayStation

NW Bio receives decision to continue Phase III clinical trial on brain cancer in Germany

Study: Immune-regulating molecules can trigger lymphomas

NCI renews UCLA prostate SPORE grant

Study reveals nearly 40% of tumors are caused by viruses

Viewpoints: Health law rollout needs a better salesman; the overhaul is shifting the economy to part-timers

Research opens potential new avenue for cancer treatment

Study: New therapeutic approach to treat prostate cancer

Researchers reveal how SMIP004 anticancer compound targets prostate cancer cells

What to know about prostate cancer eBook

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Newsletters you may be interested in